Chief Scientific Officer @ (October 2024 - February 2026)
SVP, Head of invoX Therapeutic Innovation @ (February 2024 - October 2024)
SVP, Head of Research @ (June 2023 - February 2024)
SVP, Biology and Translational Science @ (May 2022 - June 2023)
VP, Preclinical Translational Pharmacology @ (March 2018 - May 2022)
Director, Preclinical Translational Pharmacology @ (March 2017 - March 2018)
Senior Scientist @ (May 2007 - February 2017)
Postdoctoral Researcher @ (February 2002 - May 2007)
Michelle Morrow Education
University of Cambridge
Doctor of Philosophy (Ph.D.) (Immunology)
1998-2002
Newcastle University
Bachelor’s Degree (Molecular Biology)
1995-1998
Michelle Morrow Summary
Michelle Morrow, based in Hitchin, GB, is currently a Chief Scientific Officer at Nucleome Therapeutics. Michelle Morrow brings experience from previous roles at Avacta, invoX Pharma and F-star, an invoX company. Michelle Morrow holds a 1998 - 2002 Doctor of Philosophy (Ph.D.) in Immunology @ University of Cambridge. Michelle Morrow has 1 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Michelle Morrow?
Find contact details for 700 million professionals.